Open Monoclonal Technology Overview

Life ScienceCompany

Was Open Monoclonal Technology formerly PE-backed?

Yes. Open Monoclonal Technology was formerly owned by 1 private investor.

Where is Open Monoclonal Technology headquartered?

Open Monoclonal Technology is headquartered in Palo Alto, California.

What sector is Open Monoclonal Technology in?

Open Monoclonal Technology is a life science company.

When was Open Monoclonal Technology founded?

Open Monoclonal Technology was founded in 2007.

Acquired by Ligand Pharmaceuticals, Inc. (Company) on 2015-12-17

Open Monoclonal Technology, Inc. (OMT)

2747 Ross Road, Suite A,
Palo Alto, California 94303
United States,
(650) 224-6835
www.openmonoclonaltechnology.com

Open Monoclonal Technology, Inc. (OMT) is a biotechnological company provides genetic engineering of animals for discovery of human therapeutic antibodies, naturally optimized human antibodies® and the only company with three transgenic animal platforms, collectively known as OmniAb™. All OmniAb platforms — OmniRat®, OmniMouse®, and OmniFlic™ — have broad freedom to operate, are protected by new patents and patent applications, and are available for all targets and indications

Company Summary

SECTOR

Life Science

Established

2007

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.8K Private Equity Firms
214K M&A Transactions
216K Companies Involved in M&A
(Buyer, Seller, or Target)
3.8K M&A Advisors
(Investment Banks and Law Firms)
83K M&A Contacts
(PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Open Monoclonal Technology

California Companies , Life Science Companies , United States Companies , California Life Science Companies , California Life Science with Acquisitions , California Life Science with Divestitures

Related Lists for California Companies

Largest California Companies , Acquisitive California Companies , Recently Acquired California Companies , Recently Sold California Companies , Private California Companies , Public California Companies , Acquired California Companies , PE Backed California Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies